In Vitro Toxicity Testing Market to Reach $28.0 Billion by 2030, Driven by Rising R&D Costs and Regulatory Push for Animal Testing Alternatives

According to BCC Research, the global market is projected to grow from $17.4 billion in 2025 to $28 billion by 2030, driven ...
Nature

In Vitro Cytotoxicity Testing and Toxicity Assessment

The increasing need to evaluate chemical safety without relying on animal models has driven the refinement and diversification of in vitro cytotoxicity assays. These tests involve exposing cultured ...
The Conversation

How do researchers determine how toxic a chemical is? A toxicologist explains alternatives to animal testing

So many chemicals to test, so little resources and time. Adam Gault/OJO Images via Getty Images A vast number of chemicals are registered for production and use around the world. But only a portion ...
IFLScience

Is Animal Testing Necessary – And Where Are We On Alternatives?

Katie has a PhD in maths, specializing in the intersection of dynamical systems and number theory. She reports on topics from maths and history to society and animals. Katie has a PhD in maths, ...
HUB

Reimagining alternatives to animal testing

Around 348 B.C., Aristotle took a two-year trip to the eastern Aegean island of Lesbos to study animals in a lagoon. Along with observing the creatures in their natural habitat and surmising, among ...
The Scientist

Is This the End of Animal Testing? FDA Announces Plans to Phase Out Animals in Drug Safety Studies

Organoids, organs-on-a-chip, and machine learning technologies have improved dramatically in recent years, but have they come far enough to replace animal research? Additionally, despite attempts to ...
GEN

The Impact of FDA’s Animal Use Shift on the Future of Preclinical Testing

AI-based approaches are increasingly capturing complex human disease biology directly, without the use of potentially confounding animal models. [ignatiev / Getty Images] The recent decision by the ...
RAPS

FDA drafts guidance on animal testing alternatives

The US Food and Drug Administration (FDA) has released draft guidance aimed at assisting pharmaceutical manufacturers in transitioning from animal studies to non-animal alternatives for drug ...
Healio

FDA efforts to reduce animal testing signal shift toward AI, organ-on-chip study methods

Please provide your email address to receive an email when new articles are posted on . The FDA announced plans in 2025 to reduce animal testing requirements in biomedical research. New approach ...